Cranebio Co., Ltd.

Cranebio Co., Ltd.

Private
TokyoHealthcare & Life Scienceshttps://www.crane-bio.com/

Last Round

Series B

Jul 31, 2025

Total Funding Raised

$4.33M

Company Overview

Cranebio Co., Ltd. is a HealthTech and FemTech company that develops medical testing systems intended to provide simple, sensitive and affordable medical testing kits, including viral or bacterial gene testing kits and wearable testing kits focused on hormones and diseases peculiar to women.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

DNA origamirapid genetic testingat-home diagnosticswomen's healthfemtechpoint-of-care testingPOCTwearable diagnosticsmolecular diagnosticsPCR-equivalent sensitivitydevice-free testingartificial enzymesDozymeinfectious disease testingfood sanitation testingresearch reagents

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cranebio Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cranebio Co., Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BJul 31, 2025
Series AOct 4, 2023

Cranebio Co., Ltd. Investors

Notable investors and investment history

Cranebio Co., Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cranebio Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cranebio Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range2
Year Founded2021
Last FundingJul 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.